A Tumultuous Week at the FDA: What the Restructuring Means for Innovation and Public Health
The FDA undergoes significant restructuring, impacting thousands of jobs, including the pivotal exit of Peter Marks. Peter Marks, former head of the CBER, was instrumental in advancing cell and gene…